GC
IMGN

Guggenheim Capital’s Immunogen Inc IMGN Stock Holding History

Guggenheim Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-84,991
Closed -$2.52M – 1965
2023
Q4 		$2.52M Sell
84,991
-5,982
-7% -$119K 0.02% 762
2023
Q3 		$1.44M Buy
+90,973
New +$1.51M 0.01% 938
2018
Q4 		– Sell
-244,847
Closed -$2.32M – 2407
2018
Q3 		$2.32M Buy
244,847
+21,107
+9% +$203K 0.02% 1152
2018
Q2 		$2.18M Buy
223,740
+18,018
+9% +$190K 0.01% 1202
2018
Q1 		$2.16M Sell
205,722
-63,167
-23% -$624K 0.01% 1576
2017
Q4 		$1.72M Buy
+268,889
New +$1.66M ﹤0.01% 1777
2016
Q2 		– Sell
-227,055
Closed -$1.94M – 2942
2016
Q1 		$1.94M Buy
227,055
+47,941
+27% +$406K 0.01% 1593
2015
Q4 		$2.43M Buy
179,114
+61,331
+52% +$755K 0.01% 1472
2015
Q3 		$1.13M Buy
+117,783
New +$1.72M ﹤0.01% 2022
2015
Q1 		– Sell
-301,045
Closed -$1.84M – 3089
2014
Q4 		$1.84M Buy
301,045
+55,875
+23% +$511K ﹤0.01% 1788
2014
Q3 		$2.6M Buy
245,170
+25,952
+12% +$294K 0.01% 1580
2014
Q2 		$2.6M Sell
219,218
-30,302
-12% -$380K 0.01% 1602
2014
Q1 		$3.73M Buy
249,520
+30,370
+14% +$479K 0.01% 1309
2013
Q4 		$3.21M Sell
219,150
-14,491
-6% -$223K 0.01% 1358
2013
Q3 		$3.98M Buy
233,641
+48,971
+27% +$861K 0.01% 1209
2013
Q2 		$3.06M Buy
+184,670
New +$2.99M 0.01% 1287

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Guggenheim Capital's IMGN Position: Q1 2024 in Review

Guggenheim Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 84,991 shares — an estimated $2.52M sold.

Guggenheim Capital first reported a position in IMGN in Q2 2013 and held it in 16 quarters. The position peaked at $3.98M in Q3 2013. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Guggenheim Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Guggenheim Capital sold 84,991 Immunogen Inc shares in Q1 2024, an estimated $2.52M.
  • Guggenheim Capital first reported a position in Immunogen Inc in Q2 2013 and held it in 16 quarters.
  • Guggenheim Capital's Immunogen Inc position peaked at $3.98M in Q3 2013.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Guggenheim Capital's 13F filing for Q1 2024, filed 14 May 2024.